As you may see , apart from the usual ordinary session we will have two back-to-back meeting, as
follows:
•
11h30 to 12h15 a meeting with
AstraZeneca representatives who will provide a progress on
regulatory submission and an update of the Phase 3 interim analysis data focusing on the effect
of the inter-dose interval on immune response and vaccine efficacy. They will also answer any
questions your may have.
•
13h30 to 13h45 a meeting with
Moderna representatives who will provide an update on next
week's deliveries.
Please note that for each of these two meetings you will receive a
separate WebEx invitation tomorrow
morning.
With kind regards,
EC Vaccines team